معرفی
Dr. Bharat Khurana serves as Adjunct Professor at Johns Hopkins University, teaching within the MS-MBA dual-degree program offered by the School of Arts and Sciences and housed at the Center for Biotechnology Education in Baltimore, Maryland. Parallel to his academic role, he is Global Regulatory Lead, Vaccine Business Unit at Takeda Pharmaceuticals in Cambridge, MA, and has over a decade of prior experience at the U.S. FDA’s Center for Biologics Evaluation and Research (CBER).
Education & Training:
- DVM – India (veterinary medicine)
- PhD – Germany, Cell & Molecular Biology, 2001
- MS-MBA – Johns Hopkins University, 2009 (specialized dual-degree program)
Research & Professional Interests:
Dr. Khurana’s career straddles cutting-edge biotechnology and global regulatory science. His bench-science foundation lies in virology, molecular and cellular biology, honed during post-doctoral appointments at NIAID/NIH and the Uniformed Services University of the Health Sciences. Transitioning to regulatory affairs, he now leverages deep expertise in clinical development, preclinical toxicology, and CMC (Chemistry, Manufacturing & Controls) to shepherd vaccines from early-phase trials through worldwide marketing applications.
At Johns Hopkins he brings real-world case studies on IND/BLA dossier preparation, FDA interactions, and global health-agency negotiations directly into the classroom, enriching the biotechnology and regulatory curricula with up-to-date industry practice.
Scientific Awards:
No specific awards are listed in the provided material.
Advising & Grants:
No named students or grant details appear in the supplied text.
Laboratories & Teams:
Dr. Khurana leads regulatory strategy for Takeda’s global vaccine portfolio and contributes to cross-functional teams spanning clinical, CMC, epidemiology, and health-economics functions.
